MedPath

Impact of GLUBLOCâ?¢ on healthy individuals

Not Applicable
Registration Number
CTRI/2023/05/052741
Lead Sponsor
My Pura Vida Wellness Private Limited (Puravida)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Aged between 18â??60 years,

2.BMI between 18.5 and 22.9 kg/m2

3.Fasting blood glucose range between 3.9 and 5.5 mmol/L

Exclusion Criteria

1.Women who were pregnant or lactating

2.Any known food allergies

3.Subjects with a bleeding disorder

4.Pre-existing medical condition or taking medication known to affect glucose regulation and/or influence digestion and absorption of nutrients

5.History of diabetes mellitus (type I/II) or they used antihyperglycaemic drugs or insulin to treat diabetes or related conditions

6.Used steroids, protease inhibitors or antipsychotic medicines as these drugs are known to impact glucose metabolism and body fat distribution.

7. Refused consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To document the impact of GLUBLOCâ?¢ supplementation on postprandial changes in plasma insulin in post-high carbohydrate meal <br/ ><br>Timepoint: Blood sample pre-intervention - Baseline sample 0 Hrs <br/ ><br>Post-intervention - 15, 30,45,60,90,120,150,180 minutes
Secondary Outcome Measures
NameTimeMethod
To document the sensitivity and specificity of GLUBLOC supplementation in healthy individuals post <br/ ><br>high carb meal intakeTimepoint: Blood sample pre-intervention - Baseline sample 0 Hrs <br/ ><br>Post-intervention - 15, 30,45,60,90,120,150,180 minutes
© Copyright 2025. All Rights Reserved by MedPath